Digestive tract tumor is a high incidence tumor in China, including esophageal cancer, stomach cancer, liver cancer, colorectal cancer, cholangiocarcinoma, etc., which is an important systemic disease that seriously affects the health of Chinese people. The incidence of digestive tract tumors in China is more than half of the world, and the overall diagnosis and treatment level needs to be further improved. In the era of rapid development of immunotherapy, patients with digestive tract tumors are a very special group of people who are relatively immune tolerant and lack breakthrough progress. Further communication and exploration of other groups that may benefit from immunotherapy are still needed.

Therefore, in order to promote academic exchanges and improve the diagnosis and treatment level of digestive system tumors, immunotherapy and other therapeutic means are discussed in depth. The "2024 Gastrointestinal Cancer Multidisciplinary Standardized Diagnosis and Treatment Salon" sponsored by High-tech Medical Association was successfully held online. This meeting hired experts from both inside and outside the province to teach digestive tract and tumor-related fields, which involved a wide range of content and was closer to clinical practice, with strong advancement, practicability and maneuverability, and was worthy of learning by grassroots physicians. More than 50 attendees online.